Plasma Glucose Levels Affect Cerebral 18F-FDG Distribution in Cognitively Normal Subjects With Diabetes

Clinical Nuclear Medicine

Volumn 41, Issue 6, 2016, Pages e274-e280

  Ishibashi, Kenji ^a   Onishi, Airin ^a   Fujiwara, Yoshinori ^a   Ishiwata, Kiichi ^a   Ishii, Kenji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

18 F FDG; Alzheimer disease; diabetes; glucose; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLICLAZIDE; GLIMEPIRIDE; GLUCOSE; LINAGLIPTIN; GLUCOSE BLOOD LEVEL;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; FRONTAL CORTEX; GLUCOSE BLOOD LEVEL; HUMAN; LONGITUDINAL STUDY; MALE; NEUROIMAGING; PARIETAL CORTEX; PET SCANNER; PLASMA; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRECUNEUS; RATING SCALE; VOXEL BASED MORPHOMETRY; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ALZHEIMER DISEASE; BLOOD GLUCOSE; BRAIN; COGNITION; DIABETES MELLITUS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84957837322     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000001147     Document Type: Article

References (35)

1. Phelps ME, Huang SC, Hoffman EJ, Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy- d -glucose: validation of method. Ann Neurol. 1979; 6: 371-388.
2. Wang GJ, Volkow ND, Wolf AP, Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med. 1994; 35: 1457-1466.
3. Suhonen-Polvi H, Ruotsalainen U, Kinnala A, FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization. J Nucl Med. 1995; 36: 1249-1254.
4. Keyes JW Jr,. SUV: standard uptake or silly useless value? J Nucl Med. 1995; 36: 1836-1839.
5. Huang SC,. Anatomy of SUV. Standardized uptake value. Nucl Med Biol. 2000; 27: 643-646.
6. Yakushev I, Hammers A, Fellgiebel A, SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage. 2009; 44: 43-50.
7. Friedland RP, Budinger TF, Ganz E, Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr. 1983; 7: 590-598.
8. Langbaum JB, Chen K, Lee W, Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage. 2009; 45: 1107-1116.
9. Kawasaki K, Ishii K, Saito Y, Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann Nucl Med. 2008; 22: 191-200.
10. Burns CM, Chen K, Kaszniak AW, Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology. 2013; 80: 1557-1564.
11. Ishibashi K, Kawasaki K, Ishiwata K, Reduced uptake of F-FDG and O-HO in Alzheimer's disease-related regions after glucose loading. J Cereb Blood Flow Metab. 2015; 35: 1380-1385.
12. Ishibashi K, Onishi A, Fujiwara Y, Relationship between Alzheimer disease-like pattern of 18 F-FDG and fasting plasma glucose levels in cognitively normal volunteers. J Nucl Med. 2015; 56: 229-233.
13. Ishibashi K, Miura Y, Oda K, Alzheimer's disease-like pattern of (18)F-FDG uptake during a hyperglycemic state and negative (11)C-PiB binding in a patient with mild cognitive impairment. J Alzheimers Dis. 2014; 42: 385-389.
14. Albert MS, DeKosky ST, Dickson D, The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7: 270-279.
15. Bartlett EJ, Brodie JD, Wolf AP, Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab. 1988; 8: 502-512.
16. Tyler JL, Strother SC, Zatorre RJ, Stability of regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. J Nucl Med. 1988; 29: 631-642.
17. Maquet P, Dive D, Salmon E, Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy- d -glucose method in resting, healthy human subjects. Eur J Nucl Med. 1990; 16: 267-273.
18. Wahl RL, Henry CA, Ethier SP,. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy- d -glucose in rodents with mammary carcinoma. Radiology. 1992; 183: 643-647.
19. Hara T, Higashi T, Nakamoto Y, Significance of chronic marked hyperglycemia on FDG-PET: is it really problematic for clinical oncologic imaging? Ann Nucl Med. 2009; 23: 657-669.
20. Yamada K, Endo S, Fukuda H, Experimental studies on myocardial glucose metabolism of rats with 18 F-2-fluoro-2-deoxy- d -glucose. Eur J Nucl Med. 1985; 10: 341-345.
21. Marian T, Balkay L, Fekete I, Hypoglycemia activates compensatory mechanism of glucose metabolism of brain. Acta Biol Hung. 2001; 52: 35-45.
22. Wienhard K,. Measurement of glucose consumption using [(18)F]fluorodeoxyglucose. Methods. 2002; 27: 218-225.
23. Baker LD, Cross DJ, Minoshima S, Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol. 2011; 68: 51-57.
24. Beason-Held LL,. Dementia and the default mode. Curr Alzheimer Res. 2011; 8: 361-365.
25. Fransson P, Marrelec G,. The precuneus/posterior cingulate cortex plays a pivotal role in the default mode network: evidence from a partial correlation network analysis. Neuroimage. 2008; 42: 1178-1184.
26. Utevsky AV, Smith DV, Huettel SA,. Precuneus is a functional core of the default-mode network. J Neurosci. 2014; 34: 932-940.
27. Cavanna AE, Trimble MR,. The precuneus: A review of its functional anatomy and behavioural correlates. Brain. 2006; 129: 564-583.
28. Sperling RA, Laviolette PS, O'Keefe K, Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009; 63: 178-188.
29. Musen G, Jacobson AM, Bolo NR, Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes. 2012; 61: 2375-2379.
30. Rami L, Sala-Llonch R, Sole-Padulles C, Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease. J Alzheimers Dis. 2012; 31: 517-526.
31. Dore V, Villemagne VL, Bourgeat P, Cross-sectional and longitudinal analysis of the relationship between Abeta deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. JAMA Neurol. 2013; 70: 903-911.
32. Varrone A, Asenbaum S, Vander Borght T, EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009; 36: 2103-2110.
33. Vincent AM, Russell JW, Low P, Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004; 25: 612-628.
34. Goh SY, Cooper ME,. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008; 93: 1143-1152.
35. Yang Y, Song W,. Molecular links between Alzheimer's disease and diabetes mellitus. Neuroscience. 2013; 250: 140-150.